Real-world effectiveness and rheumatologist satisfaction with secukinumab in the treatment of patients with axial spondyloarthritis

Kiltz, U, Keininger, DL, Holdsworth, EA et al. (5 more authors) (2022) Real-world effectiveness and rheumatologist satisfaction with secukinumab in the treatment of patients with axial spondyloarthritis. Clinical Rheumatology, 41. pp. 471-481. ISSN 0770-3198

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © International League of Associations for Rheumatology (ILAR) 2021. This is an author produced version of an article published in Clinical Rheumatology. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: Axial spondyloarthritis; Patient-reported outcomes; Real-world effectiveness; Secukinumab; Treatment duration
Dates:
  • Accepted: 4 October 2021
  • Published (online): 20 November 2021
  • Published: February 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Musculoskeletal Medicine & Imaging (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 25 Oct 2021 10:01
Last Modified: 01 Feb 2022 15:34
Status: Published
Publisher: Springer
Identification Number: https://doi.org/10.1007/s10067-021-05957-4

Download

Accepted Version


Embargoed until: 20 November 2022

Filename: AxSpA Sec TX satis effectiveness.pdf

Request a copy

file not available

Share / Export

Statistics